Showing results (31-40 of 693) with videos related to

Sort By:
Pageof 70
Acta Crystallographica. Section E, Crystallographic Communications|February 1, 2021
Two acyclic imides: 3-bromo-N-(3-bromo-benzo-yl)-N-(pyridin-2-yl)benzamide and 3-bromo-N-(3-bromo-benzo-yl)-N-(pyrimidin-2-yl)benzamideFéilim Desmond, John F Gallagher, Niall Hehir
Acta Crystallographica. Section E, Crystallographic Communications|September 11, 2023
The unusual (syn-/anti-)2 conformation of a di-meth-oxy-pyrimidyl-based tennimidePavle Mocilac, Fabian Pohl, John F Gallagher
Physical Review Letters|July 15, 2003
Fano line shapes reconsidered: symmetric photoionization peaks from pure continuum excitationU Eichmann, T F Gallagher, R M Konik
Clinical Pharmacology and Therapeutics|April 22, 2011
Prevention of potentially inappropriate prescribing for elderly patients: a randomized controlled trial using STOPP/START criteriaP F Gallagher, M N O'Connor, D O'Mahony
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
2-Ferrocenyl-N-(2-ferrocenylbenzo-yl)-N-(4-methyl-2-pyrid-yl)benzamideJohn F Gallagher, Steven Alley, Alan J Lough
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
2-Ferrocenyl-N-(6-methyl-2-pyrid-yl)benzamideJohn F Gallagher, Steven Alley, Alan J Lough
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
3-Fluoro-N-(3-fluoro-benzo-yl)-N-(2-pyrid-yl)benzamideJohn F Gallagher, Katie Donnelly, Alan J Lough
BMC Geriatrics|January 30, 2009
Inappropriate prescribing and adverse drug events in older peopleHilary J Hamilton, Paul F Gallagher, Denis O'Mahony
Pageof 70